◍wovepaper
SearchResearchersInstitutions
Sign in
institution

Janssen Research & Development (United States)

United States

1 paper here36 citations across 1
fields
  • q-bio.OT1
ROR 05wae1a98OpenAlex

affiliations via OpenAlex

most citedAssessing the Impact of COVID-19 on the Objective and Analysis of Oncology Clinical Trials -- Application of the Estimand Framework

36 citations

researchers with a paper here
  • E. Degtyarev1 · h 14
  • Feng Liu1 · h 4
  • Godwin Yung1 · h 8
  • Jiangxiu Zhou1 · h 6
  • J. Siegel1 · h 6
  • K. Rufibach1 · h 41
  • M. Casey1 · h 24
  • Oliver Sailer1 · h 6
  • R. Tang1 · h 8
  • S. Englert1 · h 19
  • Shentu Yue1 · h 3
  • Steven Sun1 · h 20
collaborating institutions
  • AbbVie (Germany)DE1 paper
  • Bayer (United States)US1 paper
  • Boehringer Ingelheim (Germany)DE1 paper
  • GlaxoSmithKline (United States)US1 paper
  • Merck & Co., Inc., Rahway, NJ, USA (United States)US1 paper
  • Nektar Therapeutics (United States)US1 paper
  • Novartis (Switzerland)CH1 paper
  • Pfizer (United States)US1 paper
  • Roche (Switzerland)CH1 paper

1 paper

q-bio.OT2020★ 36 cited

Assessing the Impact of COVID-19 on the Objective and Analysis of Oncology Clinical Trials -- Application of the Estimand Framework

Evgeny Degtyarev, Kaspar Rufibach, Yue Shentu +10

COVID-19 outbreak has rapidly evolved into a global pandemic. The impact of COVID-19 on patient journeys in oncology represents a new risk to interpretation of trial results and it…

◍wovepaper

Papers, researchers and institutions, woven together.

Explore
  • Search
  • Researchers
  • Institutions
Account
  • Library
  • Chat
Data
  • arXiv.org
  • Semantic Scholar
  • OpenAlex
  • Latest RSS
AboutContactPrivacyDevelopersllms.txtopenapi.json
Not affiliated with arXiv. Researcher data from Semantic Scholar (ODC-BY) and OpenAlex.